Analysts think LIVN stock price could increase by 45%
Aug 01, 2024, 6:25 AM
2.04%
What does LIVN do
LivaNova Plc specializes in medical technology, developing and selling products for cardiological and neurological therapies, including heart-lung machines and neuromodulation devices for epilepsy and depression. Its business divisions include Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support.
11 analysts think LIVN stock price will increase by 44.56%. The current median analyst target is $71.40 compared to a current stock price of $49.39. The lowest analysts target is $57.57 and the highest analyst target is $94.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
